Anzeige
Mehr »
Dienstag, 21.04.2026 - Börsentäglich über 12.000 News
BREAKING: Pacifica liefert hochgradige Treffer - Phase II trifft genau ins Ziel
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 692614 | ISIN: SG0505000059 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
Singapur
1-Jahres-Chart
ASIAMEDIC LIMITED Chart 1 Jahr
5-Tage-Chart
ASIAMEDIC LIMITED 5-Tage-Chart

Aktuelle News zur ASIAMEDIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - CEO-
MoASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (ANG HAO YAO)-
MoASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (INTEGRAL LEAD LIMITED)-
MoASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (DRAGON GLORIOUS LIMITED) -
MoASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)-
MoASIAMEDIC LIMITED: EMPLOYEE STOCK OPTION/SHARE SCHEME::ISSUE AND ALLOTMENT OF SHARES PURSUANT TO THE ASIAMEDIC ESOS 20161
ASIAMEDIC Aktie jetzt für 0€ handeln
13.04.ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER3
13.04.ASIAMEDIC LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS1
13.04.ASIAMEDIC LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::DISCREPANCIES BETWEEN UNAUDITED AND AUDITED ACCOUNTS1
13.04.ASIAMEDIC LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY-
08.04.ASIAMEDIC LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::RETIREMENT OF DIRECTOR1
06.04.ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (INTEGRAL LEAD LIMITED)-
06.04.ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (DRAGON GLORIOUS LIMITED)-
06.04.ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (CAPITAL BLAZE LIMITED)-
06.04.ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (ANG HAO YAO)-
06.04.ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - CEO-
06.04.ASIAMEDIC LIMITED: EMPLOYEE STOCK OPTION/SHARE SCHEME::ISSUE AND ALLOTMENT OF SHARES AND USE OF TREASURY SHARES PURSUANT TO THE ASIAMEDIC ESOS 20163
30.03.ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER1
01.03.ASIAMEDIC LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS-
13.08.25AsiaMedic Limited: AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance358SINGAPORE, Aug 13, 2025 - (ACN Newswire) - SGX Catalist-listed AsiaMedic Limited (the "Company" and, together with its subsidiaries, the "Group") announced its unaudited financial results for the six...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1